Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LTV1 ribosome biogenesis factor pseudogene 1 (LTV1P1) is a human pseudogene, meaning it is a genomic DNA sequence similar to the functional LTV1 gene but does not encode an active protein. LTV1P1 does not participate in ribosome biogenesis and is not involved in any known molecular pathways or diseases. Its entry may be confused with the protein-coding gene LTV1, which is essential for ribosome assembly and whose mutations cause defects in cell growth and embryogenesis in model organisms[2][3][5]. However, LTV1P1 itself is not a therapeutic target, receptor, enzyme, transporter, or any protein involved in pharmacology or disease. Any references associating LTV1P1 with drug targeting or disease roles are incorrect and result from mistaking the pseudogene for the functional LTV1 gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LTV1 ribosome biogenesis factor pseudogene 1 (LTV1P1).